Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1251903 | 0.97 | — | — | |
| Acetic Acid SCHEMBL1550886 | 0.94 | FFAR3 (0.44) | FFAR3LCKFYNLMNAOR51E2 | |
| Acetone SCHEMBL7633158 | 0.87 | — | — | |
| Acetic Acid SCHEMBL10906963 | 0.79 | FFAR3 (0.58) | FFAR3LCKFYNLMNAALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL894688 | 0.79 | — | — | |
| Acetic Acid SCHEMBL28068869 | 0.78 | — | — | |
| Dichloropropane SCHEMBL7286529 | 0.78 | — | — | |
| Acetic Acid SCHEMBL654439 | 0.78 | FFAR3 (0.47) | FFAR3LCKFYNLMNAOR51E2 | |
| Acetic Acid SCHEMBL9534162 | 0.77 | FFAR3 (0.39) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL4097452 | 0.76 | FFAR3 (0.54) | FFAR3LCKFYNLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992473-B2 | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity | Epitracker, Inc. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20240124936-A1 | PROTEIN AND METABOLITE BLOOD BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S R L (IT) | 2024-04-18 | — | — | US | disclosed |
| EP-3174991-B1 | METHODS, COMPOSITIONS, AND KITS FOR ANALYSIS OF STRUCTURALLY DIVERSE COMPLEX LIPIDS | METABOLON INC (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20230080158-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S.R.L. (IT) | 2023-03-16 | — | — | US | disclosed |
| US-11181535-B2 | Isotopically-labeled cholesteryl ester internal standard composition and kit | METABOLON, INC. (US) | 2021-11-23 | — | — | US | disclosed |
| EP-3908374-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES | Epitracker, Inc. (US) | 2021-11-17 | — | — | EP | disclosed |
| US-20210346419-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY | Epitracker, Inc. | 2021-11-11 | — | — | US | disclosed |
| US-20210330734-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES | Epitracker, Inc. | 2021-10-28 | — | — | US | disclosed |
| WO-2021161208-A1 | SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME | CARDIOMIX S.R.L. (IT) | 2021-08-19 | — | — | WO | disclosed |
| EP-3796976-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY | Epitracker, Inc. (US) | 2021-03-31 | — | — | EP | disclosed |
| US-20210052535-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY | Epitracker, Inc. | 2021-02-25 | — | — | US | disclosed |
| WO-2020146263-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES | Epitracker, Inc. (US) | 2020-07-16 | — | — | WO | disclosed |
| US-20170370954-A1 | Biomarkers for Fatty Liver Disease and Methods Using the Same | METABOLON, INC. | 2017-12-28 | — | — | US | disclosed |
| EP-3221463-A1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20170192023-A1 | METHODS, COMPOSITIONS, AND KITS FOR ANALYSIS OF STRUCTURALLY DIVERSE COMPLEX LIPIDS | METABOLON, INC. | 2017-07-06 | — | — | US | disclosed |
| WO-2016081534-A1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | METABOLON, INC. (US) | 2016-05-26 | — | — | WO | disclosed |
| WO-2007128137-A1 | POLY(ARYLENE ETHER)S WITH GRAFTING CAPABILITY FROM A BISPHENOL OR BISTHIOPHENOL MONOMER | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-11-15 | — | — | WO | disclosed |